More PYC Therapeutics Limited news
PYC Therapeutics LimitedASX: PYC

Phylogicas Technology is Effective in Human Cells

Aug 6, 2019 at 12:02 AM EDT · Issued by PYC Therapeutics Limited

Filed with ASX · Aug 6, 2019 at 12:02 AM EDT

On 6ix: 6ix.com/news/phylogicas-technology-is-effective-in-human-cells

Pyc Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

PYC Therapeutics Limited on 6ix

Story so far

  • FPP Results Effective in Delivering Peptide Cancer VaccineJan 8, 2018

Earlier from PYC Therapeutics

  • Company Presentation - July 2019Jul 23, 2019
  • Operational Update and Appendix 4CJul 23, 2019
  • Animal Models - 400% Outperformance of Gold StandardJul 22, 2019
  • Break Through Animal Model ResultsJun 26, 2019
  • March 2019 Quarterly Operational Update and App4CApr 29, 2019

Later from PYC Therapeutics

  • Response to ASX Aware QueryAug 7, 2019
  • Successful Time - Course Studies in AnimalsAug 22, 2019
  • Successful Competitive Drug Evaluation in AnimalsSep 2, 2019
  • Strategic Partnership and Lead ProgramOct 1, 2019
  • Successful Major Milestone - Human Retina in a Dish ModelsOct 8, 2019
All PYC Therapeutics news releases↗

Follow PYC Therapeutics into a list and get an email when it puts out news.

Follow PYC Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer